Novel jnk inhibitor molecules for treatment of various diseases
CA2807036A1
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
WO2011160653A1
Novel jnk inhibitor molecules
WO2010072228A1
Novel transporter constructs and transporter cargo conjugate molecules
WO2009143865A1
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
WO2009143864A1
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
AU2008201592A1
Intracellular Delivery of Biological Effectors
AU2007216926A1
Intracellular Delivery of Biological Effectors by Novel Transporter Peptide Sequences
EP1884521A1
Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
WO2007031098A1
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
EP1661912A1
Fusion protein comprising a BH3-domain of a BH3-only protein
EP1656951A1
Conjugates with enhanced cell uptake activity
EP1970070A2
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US7803749B2
Peptide inhibitors of MKK7 kinase binding to insulin binding proteins
